International Society for the Study of Women's Sexual Health

NEWS

DYSPAREUNIA: CMS CLARIFICATION RESULTS IN EXPANDED TREATMENT AND COVERAGE UNDER MEDICARE PART D

ISSWSH is pleased to announce and recognize the Centers for Medicare and Medicaid Services (CMS) clarification of the statutory intent of “Prescription Drug Benefits” section 1860D-2(e)(2)(A) of the Social Security Act, stating that drugs for the treatment of moderate to severe dyspareunia (pain during sexual intercourse) due to menopause, are not excluded from Medicare Part D coverage when used consistent with this labeling.

ISSWSH, alongside the North American Menopause Society (NAMS), the American College of Obstetricians and Gynecologists (ACOG), and many other interested parties are committed to women’s health and particularly sexual health. James A. Simon, MD, President of ISSWSH, thanks these partners and commends CMS for this clarification that now allows women suffering from dyspareunia, to access expanded treatment options and get coverage under Medicare Part D.

View Press Release

Save the Date

ISSWSH Fall Course 2018
November 15-17, 2018   177 days left
DoubleTree Hilton Hotel, Scottsdale, AZ - USA
Read more...

ISSWSH / ISSM Joint Meeting 2019
March 7-10, 2019   289 days left
Atlanta, GA, USA

Latest Tweets

Women's experiences of #sexualfunctioning in the early weeks of #breastcancer treatment https://t.co/nRjOf5sYJy ISSWSH
Proud to announce an important collaboration with @MenopauseOrg on the management of genitourinary symptoms of… https://t.co/dEHmDlWIRz ISSWSH
An Extensive Review of all Energy Sources for Pelvic Floor. Laser therapy for the restoration of vaginal function.… https://t.co/BYLqptKIZh ISSWSH

Contact Details

ISSWSH Executive Office
14305 Southcross Dr
Suite 100
Burnsville, MN 55306
USA

Phone: +1 (952) 683 9025
Fax: +1 (952) 314 8212
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.